According to a report from market analysis company Frost & Sullivan, hybrid imaging platforms represent a significant advancement for clinicians by presenting them with both anatomical and physiological images of patients' organs, tissues, and tumors in a single scan. Market analysts report that these platforms have widespread applications in cardiology, oncology, brain imaging, drug discovery and personalized medicine.